FDA citizen petition

Makers of Proactiv, Clearasil, and Others Sued in Benzoyl Peroxide Acne Product Class Action

Retrieved on: 
Friday, March 8, 2024
Cream, Acne, LOS, Benzoyl peroxide, FDA, BPO, FDA citizen petition, Citizenship, Proactiv, Safety, Benzene, Public, Target

LOS ANGELES, March 8, 2024 /PRNewswire/ -- Wisner Baum filed multiple class actions alleging several companies sold benzoyl peroxide (BPO) acne products without warning consumers that they contain unsafe levels of benzene, a potent human carcinogen.

Key Points: 
  • Lab testing found numerous acne products formulated with benzoyl peroxide, including face washes, creams, and spot treatments, degrade to cancer-causing benzene under normal use and handling.
  • LOS ANGELES, March 8, 2024 /PRNewswire/ -- Wisner Baum filed multiple class actions alleging several companies sold benzoyl peroxide (BPO) acne products without warning consumers that they contain unsafe levels of benzene, a potent human carcinogen.
  • Class action attorneys Stephanie B. Sherman and R. Brent Wisner filed the complaints (Example Case: Howard et al.
  • "Our clients never would have purchased these products had they known they were exposing themselves to a dangerous carcinogen."

Photocure ASA: Results for the third quarter of 2023

Retrieved on: 
Wednesday, November 8, 2023
Cystoscopy, Standard of care, APM, Cevira, Stryker Corporation, BLC, Bladder cancer, FX, Cropping system, EBIT, Bank statement, BD, Growth, FDA citizen petition, CET, CFO, Patient, NOK, Tourism, Pharmaceutical industry, Renewable energy, EBITDA, Photocure

OSLO, Norway, Nov. 8, 2023 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million), and an EBITDA of NOK 3.3 million (NOK 4.7 million) for the company.

Key Points: 
  • OSLO, Norway, Nov. 8, 2023 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million), and an EBITDA of NOK 3.3 million (NOK 4.7 million) for the company.
  • "In the third quarter, Hexvix/Cysview revenue increased 11% year-over-year and we delivered NOK 3.3 million in EBITDA while progressing numerous initiatives to advance our business.
  • The Hexvix®/Cysview® revenues ended at NOK 107.3 million in the quarter (Q3 2022: NOK 96.9 million).
  • At the end of the third quarter of 2023, the installed base of rigid blue light cystoscopy (BLC®) systems in the U.S. was 342, an increase of 23%, or 65 towers, since the third quarter of 2022.

Photocure ASA: Results for the third quarter of 2023

Retrieved on: 
Wednesday, November 8, 2023
Cystoscopy, Standard of care, APM, Cevira, Stryker Corporation, BLC, Bladder cancer, FX, Cropping system, EBIT, Bank statement, BD, Growth, FDA citizen petition, CET, CFO, Patient, NOK, Tourism, Pharmaceutical industry, Renewable energy, EBITDA, Photocure

OSLO, Norway, Nov. 8, 2023 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million), and an EBITDA of NOK 3.3 million (NOK 4.7 million) for the company.

Key Points: 
  • OSLO, Norway, Nov. 8, 2023 /PRNewswire/ -- Photocure ASA (OSE:PHO) today reported Hexvix®/Cysview® revenues of NOK 107.3 million in the third quarter of 2023 (Q3 2022: NOK 96.9 million), and an EBITDA of NOK 3.3 million (NOK 4.7 million) for the company.
  • "In the third quarter, Hexvix/Cysview revenue increased 11% year-over-year and we delivered NOK 3.3 million in EBITDA while progressing numerous initiatives to advance our business.
  • The Hexvix®/Cysview® revenues ended at NOK 107.3 million in the quarter (Q3 2022: NOK 96.9 million).
  • At the end of the third quarter of 2023, the installed base of rigid blue light cystoscopy (BLC®) systems in the U.S. was 342, an increase of 23%, or 65 towers, since the third quarter of 2022.

10-Year-Old Celiac Activist Files Citizen Petition with the FDA to Label Gluten as a Major Food Allergen

Retrieved on: 
Wednesday, September 13, 2023
FDA, Packaging, Retail, Diabetes, Health, Manufacturing, Congressional News, Views, Public Policy, Government, White House, Federal Government, Fitness & Nutrition, Other Manufacturing, State, Local, Food, Beverage, Pillar, FDA citizen petition, Nutrition, Gluten-free diet, Prevalence, Office of Inspector General, U.S. Department of Health and Human Services, Food industry, Food Allergen Labeling and Consumer Protection Act, Public, Food safety, Fear, Eating, Hope, The Honourable, Medicine, Federal, Committee, Consumer Protection Act, Food and Agriculture Organization, White House conference, Integration, Physician, Veterans' affairs, Risk assessment, United, U.S. Department of Veterans Affairs, Office of Inspector General, Coeliac disease, Initiative, Food security, Research, Support, Conference, Generic drug, Flour, Dietary supplement, Gluten, Wheat, Hunger, Oat, Celiac

In honor of National Celiac Awareness Day and the upcoming first anniversary of the White House Conference on Hunger, Nutrition, and Health, Jax Bari, age 10, has filed a Citizen Petition with the FDA to label Gluten as a Major Food Allergen.

Key Points: 
  • In honor of National Celiac Awareness Day and the upcoming first anniversary of the White House Conference on Hunger, Nutrition, and Health, Jax Bari, age 10, has filed a Citizen Petition with the FDA to label Gluten as a Major Food Allergen.
  • Celiac Journey’s Citizen Petition is requesting a long-overdue reckoning by the FDA to better protect more than 3.3 million Americans with Celiac Disease by labeling Gluten (Wheat, Barley, Rye and Oats) as a Major Food Allergen on all packaged foods in the U.S., just like labeling Gluten is done in more than 85 other countries.
  • The Citizen Petition is actionable now under the FDA’s existing authority in the Food Allergen Labeling and Consumer Protection Act (21 U.S.C.
  • Celiac Journey is requesting that the FDA issue a rule to require that all ingredients with Gluten be declared on food labels.

Photocure ASA: Results for the second quarter and first half of 2023

Retrieved on: 
Wednesday, August 9, 2023
BLC, Citizenship, Bank statement, Cropping system, Bladder cancer, EBIT, APM, Chairperson, Traction, Patient, CEST, CFO, Growth, Cystoscopy, FDA, NOK, Ofotbanen (company), FDA citizen petition, Committee, Pharmaceutical industry, Photocure, Cevira, EBITDA

"In the second quarter of 2023, Hexvix/Cysview revenue increased 16% year over year driven by higher unit sales in the U.S., price increases and foreign exchange.

Key Points: 
  • "In the second quarter of 2023, Hexvix/Cysview revenue increased 16% year over year driven by higher unit sales in the U.S., price increases and foreign exchange.
  • Photocure reported total group revenues of NOK 144.3 million in the second quarter of 2023 (NOK 100.6 million), and an EBITDA* of NOK 23.4 million (NOK 1.4 million).
  • Photocure paid off the balance of its term debt during the second quarter of 2023.
  • We believe that this momentum will result in a strong second half of the year for new tower placements," Schneider adds.

Fungi Perfecti® Publishes an Open Letter in Response to Nammex Citizen Petition

Retrieved on: 
Wednesday, June 21, 2023
Climate Positive Development Program, Mycelium, Multimedia, System, Carbon, Fungus, Paul Stamets, Criticism of the Food and Drug Administration, FDA citizen petition, Host, Confusion, Health, FDA, Initiative, Food, Disease, Dietary supplement, Fungiculture, Truffle

This joint letter comes in response to the puzzling opinion presented in the recent FDA Citizen Petition filed by Nammex, which obfuscates and misrepresents the use of well-established mycological definitions that impact responsible consumer messaging about mushroom products.

Key Points: 
  • This joint letter comes in response to the puzzling opinion presented in the recent FDA Citizen Petition filed by Nammex, which obfuscates and misrepresents the use of well-established mycological definitions that impact responsible consumer messaging about mushroom products.
  • Specifically of concern, the Citizen Petition advocates to eliminate use of the word "mushroom" for products using mushroom mycelium.
  • In our opinion, the proposals being advocated by Nammex in their Citizen Petition do neither.
  • Fungi Perfecti® - makers of Host Defense® Mushrooms™ - is a family-owned company specializing in mushroom mycelium-based supplements and drink mixes.

CASSAVA SCIENCES INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA

Retrieved on: 
Saturday, August 13, 2022
Class Action Lawsuit, Professional Services, Legal, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Citizenship, LLC, Lists of schools in England, Company, FDA citizen petition, KSF, Food, Private investigator, Cassava

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Cassava Sciences, Inc. (NasdaqCM: SAVA).

Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Cassava Sciences, Inc. (NasdaqCM: SAVA).
  • Then, on August 27, 2021, Quanterix issued a statement denying the Companys claims, stating that it did not interpret the test results or prepare the data.
  • KSFs investigation is focusing on whether Cassavas officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

Cassava Sciences, Inc. Investors: Company Investigated by the Portnoy Law Firm

Retrieved on: 
Thursday, July 21, 2022
Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lists of schools in England, FDA citizen petition, GLOBE, Review, Citizenship, Company, Food

LOS ANGELES, July 21, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cassava Sciences, Inc. (NasdaqCM: SAVA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.

Key Points: 
  • LOS ANGELES, July 21, 2022 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Cassava Sciences, Inc. (NasdaqCM: SAVA) investors that the firm has initiated an investigation into possible securities fraud and may file a class action on behalf of investors.
  • Cassava investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq.
  • The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors options for pursuing claims to recover their losses.
  • The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing.

CASSAVA SCIENCES INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Cassava Sciences, Inc. - SAVA

Retrieved on: 
Saturday, July 16, 2022
Class Action Lawsuit, Professional Services, Legal, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Citizenship, Lists of schools in England, LLC, FDA citizen petition, Company, KSF, Private investigator, Cassava

Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Cassava Sciences, Inc. (NasdaqCM: SAVA).

Key Points: 
  • Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (KSF), announces that KSF has commenced an investigation into Cassava Sciences, Inc. (NasdaqCM: SAVA).
  • Then, on August 27, 2021, Quanterix issued a statement denying the Companys claims, stating that it did not interpret the test results or prepare the data.
  • KSFs investigation is focusing on whether Cassavas officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

KEHO Named "Mindful Start Up of the Year" In 2022 Mindful Awards Program

Retrieved on: 
Wednesday, June 8, 2022
Mindfulness, Life, Goal, Nutrition labeling requirements of the Affordable Care Act, Spice, Citizenship, CEO, Founder, Mark (given name), KEHO, Review, OK, Egg, Health, Honey, Nut, Tex-Mex, Leadership, Obesity, LOS, Water, Oil, Taste, FDA citizen petition, Video game, Fast food, Convenience food, Animal, Snack

LOS ANGELES, June 8, 2022  /PRNewswire-PRWeb/ -- The 2022 Mindful Awards Program, an independent recognition platform highlighting conscious companies and products that mindfully make waves in the ever-expanding world of consumer-packaged goods, today announced that KEHO, the first real food savory snack bite, has been named "Mindful Start Up of the Year."

Key Points: 
  • Annual Awards Program Recognizes Top Mindful Companies, Services and Products Within the Packaged Goods Industry
    LOS ANGELES, June 8, 2022 /PRNewswire-PRWeb/ -- The 2022 Mindful Awards Program , an independent recognition platform highlighting conscious companies and products that mindfully make waves in the ever-expanding world of consumer-packaged goods, today announced that KEHO , the first real food savory snack bite, has been named "Mindful Start Up of the Year."
  • Featured KEHO snacks include: curry, pizza, tex mex and thai - with the taste derived from the actual ingredients - not flavoring.
  • The mission of the Mindful Awards program is to honor conscious companies and products that do what's right for people and the planet.
  • The Mindful Awards organization is devoted to honoring mindful companies in the consumer-packaged goods industry that are setting the foundation for our future.